GC
LFCR icon

Grizzlyrock Capital’s Lifecore Biomedical LFCR Stock Holding History

Grizzlyrock Capital’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$541K Sell
103,000
-724,488
-88% -$3.65M 0.38% 20
2026
Q1 		$3.08M Buy
827,488
+84,247
+11% +$582K 2.44% 14
2025
Q4 		$6.08M Buy
743,241
+4,359
+0.6% +$32.2K 4.55% 12
2025
Q3 		$5.44M Buy
738,882
+4,349
+0.6% +$32.9K 4.22% 13
2025
Q2 		$5.96M Buy
+734,533
New +$4.95M 4.06% 11

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Grizzlyrock Capital's LFCR Position: Q2 2026 in Review

Grizzlyrock Capital reduced its Lifecore Biomedical (LFCR) stake by 88% in Q2 2026, selling an estimated $3.65M and leaving 103,000 shares worth $541K. The position accounts for 0.38% of the portfolio, ranked #20.

Grizzlyrock Capital first reported a position in LFCR in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.08M in Q4 2025. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Grizzlyrock Capital held 103,000 shares of Lifecore Biomedical worth $541K as of Q2 2026.
  • Grizzlyrock Capital sold 724,488 Lifecore Biomedical shares in Q2 2026, an estimated $3.65M.
  • Lifecore Biomedical made up 0.38% of Grizzlyrock Capital's portfolio in Q2 2026, its #20 holding.
  • Grizzlyrock Capital first reported a position in Lifecore Biomedical in Q2 2025 and has held it in 5 quarters since.
  • Grizzlyrock Capital's Lifecore Biomedical position peaked at $6.08M in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Grizzlyrock Capital's 13F filing for Q2 2026, filed 14 Aug 2026.